Implementation of a National Measles Elimination Program in Iran: Phylogenetic Analysis of Measles Virus Strains Isolated during 2010-2012 Outbreaks

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Salimi, Vahid ^a   Abbasi, Simin ^a   Zahraei, Seyed Mohsen ^b   Fatemi Nasab, Ghazal ^a   Adjaminezhad Fard, Fatemeh ^a   Shadab, Azadeh ^a   Ghavami, Nastaran ^a   Zareh Khoshchehre, Raziyeh ^a   Soltanshahi, Rambod ^b   Bont, Louis ^c   Mokhtari Azad, Talat ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CLEARANCE; EPIDEMIC; FEMALE; GENETIC VARIABILITY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; INFANT; IRAN; MALE; MEASLES; MEASLES VIRUS; MEASLES VIRUS GENOTYPE B3; MEASLES VIRUS GENOTYPE D4; MEASLES VIRUS GENOTYPE D8; MEASLES VIRUS GENOTYPE H1; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE ANALYSIS; TREND STUDY; UNINDEXED SEQUENCE; VIRAL CLEARANCE; VIRUS TRANSMISSION; YOUNG ADULT; EPIDEMIOLOGY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; NEWBORN; PHYSIOLOGY; SPECIES DIFFERENCE;

CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; IRAN; MALE; MEASLES; MEASLES VIRUS; PHYLOGENY; SPECIES SPECIFICITY;

EID: 84899683885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094846     Document Type: Article

References (23)

1. Griffin DE (2001) Measles virus. Fields virology. Lippincott Williams, and Wilkins.1401-1441 p.
2. Progress in global control and regional elimination of measles, 2000-2011. (2013) Wkly Epidemiol Rec. 88(3): 29-36.
3. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, et al. (2011) Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 204 Suppl 1: S514-523.
4. Jayamaha J, Binns PL, Fennell M, Ferson MJ, Newton P, et al. (2012) Laboratory diagnosis, molecular characteristics, epidemiological and clinical features of an outbreak of measles in a low incidence population in Australia. J Clin Virol. 54(2): 168-173.
5. Zahraei SM, Gouya MM, Azad TM, Soltanshahi R, Sabouri A, et al. (2011) Successful control and impending elimination of measles in the Islamic Republic of Iran. J Infect Dis. 204 Suppl 1: S305-311.
6. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, et al. (2007) Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J. 26(12): 1137-1141. (Pubitemid 350190947)
7. Salimi V, Mokhtari-Azad T, Abbasi S, Noroozbabaei Z, Soltan-Shahi R, et al. (2011) Molecular epidemiology of measles virus in Iran 2009-2010: first detection of measles genotype H1. J Med Virol. 83(12): 2200-2207.
8. Djebbi A, Bahri O, Mokhtariazad T, Alkhatib M, Ben Yahia A, et al. (2005) Identification of measles virus genotypes from recent outbreaks in countries from the Eastern Mediterranean Region. J Clin Virol. 34(1): 1-6. (Pubitemid 41125869)
9. Naseri M, Salimi V, Mokhtari-Azad T, Esteghamati A, Gooya M, et al. (2011) Molecular Epidemiology of Measles Virus before and after the 2003 Mass Vaccination Campaign for Measles/Rubella in Iran. Iran J Public Health. 40(1): 41-49.
10. WHO. (2007) Manual for the diagnosis of measles and rubella infection, 2nd edition. Geneva: World Health Organization.
11. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, et al. (2001) Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol. 75(9): 4399-4401. (Pubitemid 32410152)
12. Bankamp B, Byrd-Leotis LA, Lopareva EN, Woo GK, Liu C, et al. (2013) Improving molecular tools for global surveillance of measles virus. J Clin Virol.J ClinVirol. 58(1): 176-82.
13. Update of the nomenclature for describing the genetic characteristics of wildtype measles viruses: new genotypes and reference strains. (2003) Wkly Epidemiol Rec. 78(27): 229-232.
14. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 28(10): 2731- 2739.
15. Demanou M, Ratsitoharana R, Yonga M, Dosseh A, Anya B, et al. (2013) Molecular characterization of measles viruses that circulated in Cameroon between 2010 and 2011. Virol J. 10:71.
16. Vainio K, Steen TW, Arnesen TM, Ronning K, Anestad G, et al. (2012) Measles virus genotyping an important tool in measles outbreak investigation in Norway, 2011. Euro Surveill. 17(50).
17. Rota J, Lowe L, Rota P, Bellini W, Redd S, et al. (2006) Identical genotype B3 sequences from measles patients in 4 countries, 2005. Emerg Infect Dis. 12(11): 1779-1781. (Pubitemid 44674262)
18. Wairagkar N, Chowdhury D, Vaidya S, Sikchi S, Shaikh N, et al. (2011) Molecular epidemiology of measles in India, 2005-2010. J Infect Dis. 204 Suppl 1: S403-413.
19. Tricou V, Pagonendji M, Manengu C, Mutombo J, Mabo RO, et al. (2013) Measles outbreak in Northern Central African Republic 3 years after the last national immunization campaign. BMC Infect Dis. 13: 103.
20. Cheng WY, Tung HP, Wang HC, Lee LL, Wu HS, et al. (2013) Molecular epidemiology of measles virus in Taiwan in 2010-2011: the common genotype changed from H1 to D9 and the first appearance of D4. J Med Virol. 85(6): 1095-1099.
21. Carr MJ, Conway A, Waters A, Moran J, Hassan J, et al. (2009) Molecular epidemiology of circulating measles virus in Ireland 2002-2007. J Med Virol 81(1): 125-129.
22. van Binnendijk RS, van den Hof S, van den Kerkhof H, Kohl RH, Woonink F, et al. (2003) Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands. J Infect Dis. 188(6): 898-903. (Pubitemid 37176037)
23. Shakya AK, Shukla V, Maan HS, Dhole TN. (2012) Identification of different lineages of measles virus strains circulating in Uttar Pradesh, North India. Virol J. 9: 237.